Almanack Investment Partners LLC. Buys 845 Shares of Procter & Gamble Company (The) $PG

Almanack Investment Partners LLC. grew its stake in Procter & Gamble Company (The) (NYSE:PG) by 12.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,809 shares of the company’s stock after acquiring an additional 845 shares during the period. Almanack Investment Partners LLC.’s holdings in Procter & Gamble were worth $1,244,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in PG. Brighton Jones LLC grew its stake in Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after acquiring an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. grew its stake in Procter & Gamble by 10.6% in the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after acquiring an additional 277 shares in the last quarter. GAMMA Investing LLC grew its stake in Procter & Gamble by 22.4% in the 1st quarter. GAMMA Investing LLC now owns 46,658 shares of the company’s stock worth $7,951,000 after acquiring an additional 8,537 shares in the last quarter. Opal Wealth Advisors LLC bought a new position in Procter & Gamble in the 1st quarter worth about $149,000. Finally, Missouri Trust & Investment Co grew its stake in Procter & Gamble by 3.5% in the 1st quarter. Missouri Trust & Investment Co now owns 13,442 shares of the company’s stock worth $2,291,000 after acquiring an additional 457 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

PG has been the topic of a number of recent research reports. BNP Paribas Exane dropped their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. JPMorgan Chase & Co. dropped their price objective on shares of Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a research note on Friday. Barclays dropped their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. Berenberg Bank increased their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research note on Wednesday, September 17th. Finally, Wells Fargo & Company dropped their price objective on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research note on Thursday, September 25th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $172.21.

Insiders Place Their Bets

In other Procter & Gamble news, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the transaction, the chief financial officer owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. This trade represents a 18.11% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the completion of the transaction, the insider directly owned 182,422 shares of the company’s stock, valued at approximately $28,689,507.94. This represents a 5.12% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 149,763 shares of company stock valued at $23,421,279. Corporate insiders own 0.20% of the company’s stock.

Procter & Gamble Trading Down 0.6%

NYSE PG opened at $149.69 on Monday. The company has a fifty day simple moving average of $155.24 and a two-hundred day simple moving average of $159.41. The stock has a market cap of $350.34 billion, a P/E ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a 12-month low of $149.45 and a 12-month high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business’s quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the company posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.